Abstract The fungus Cunninghamella elegans is a useful model of human catabolism of xenobiotics. In this paper, the biotransformation of fluorinated biphenyls by C. elegans was investigated by analysis of the culture supernatants with a variety of analytical techniques. 4-Fluorobiphenyl was principally transformed to 4-fluoro-4′-hydroxybiphenyl, but other mono-and dihydroxylated compounds were detected in organic extracts by gas chromatography-mass spectrometry. Additionally, fluorinated water-soluble products were detected by 19 F NMR and were identified as sulphate and β-glucuronide conjugates. Other fluorobiphenyls (2-fluoro-, 4,4′-difluoro-and 2,3,4,5,6-pentafluoro-biphenyl) were catabolised by C. elegans, yielding mono-and dihydroxylated products, but phase II metabolites were detected from 4,4′-difluorobiphenyl only.
Introduction
Because of fluorine's unusual properties (high electronegativity, small Van der Waals radius, high dissociation energy of C-F), fluorinated compounds have found myriad applications such as foaming agents, blood substitutes, refrigerants, anaesthetics, lubricants and catalysts (Key et al. 1997 ). In the pharmaceutical and agricultural sectors, the number of fluorinated compounds is ever increasing; 20-25% of currently available drugs and approximately 28% of agrochemicals contain at least one fluorine atom (Jeschke 2004; Isanbor and O'Hagan 2006) . Therefore, fluorinated compounds are of serious environmental concern, yet, relatively little is known about either the fate of these compounds in natural environments or the biological effects of the compounds and their degradation products in comparison to organochlorine compounds. Nevertheless, several studies have been conducted on the microbial degradation of fluoroaromatic compounds such as fluorobenzene (Carvalho et al. 2006) , fluorobenzoate (Boersma et al. 2004 ) and fluorophenol (Ferreira et al. 2008) , demonstrating that fluorinated compounds can be catabolised via established catabolic pathways. Furthermore, improvements in analytical technologies, in particular fluorine-19 nuclear magnetic resonance ( 19 F NMR), has made detection and identification of fluorometabolites more amenable (Murphy 2007) .
Whilst several investigations have examined polychlorinated biphenyl degradation in fungi (Dietrich et al. 1995; Kamei et al. 2006) , only a handful of studies have investigated the biodegradation of fluorobiphenyl. Green et al. (1999) demonstrated that a mycorrhizal fungus was capable of biotransforming 4-fluorobiphenyl, but although six fluorometabolites were observed by 19 F NMR, only two, 4-fluoro-4′-hydroxy-and 4-fluoro-3′-hydroxybiphenyl, were identified. In another study, Murphy et al. (2008) demonstrated that the biphenyl-degrading bacterium Pseudomonas pseudoalcaligenes KF707 could degrade 2-and 4-fluorobiphenyl via the classical 'upper' pathway of biphenyl catabolism.
Cunninghamella spp. have been widely studied for their ability to degrade xenobiotic compounds, since these organisms have cyctochrome P450 enzymes and other enzymes associated with conjugation, such as sulfotransferase and glycosyl transferase (Asha and Vidyavathi 2009 ). Thus, their metabolism is seen as a model of that which occurs in mammals. There is one report of biphenyl catabolism in C. elegans (Dodge et al. 1979) , which describes the detection of mono-and dihydroxylated biphenyl and glucuronide conjugates. There are no studies describing the biotransformation of fluorinated biphenyl, although C. elegans has been shown to transform 1-fluoronaphthalene, yielding trans-3,4-and trans-5,6-dihydroxy-3,4-dihydro-1-fluoronaphthalene (Cerniglia et al. 1984) , in addition to glucoside, sulphate and glucuronic acid conjugates. In this paper, we report for the first time the degradation of fluorobiphenyl in C. elegans.
Materials and methods
Chemicals 4-Fluorobiphenyl, Sabouraud dextrose agar and broth, N-methyl-N-(trimethyl-silyl)trifluoroacetamide, sulfatase (from Helix pomatia type H-1), β-glucoronidase (from Escherichia coli) and β-glucosidase (from almonds) were purchased from Sigma. 4,4′-Difluorobiphenyl and 2,3,4,5,6-pentafluorobiphenyl were acquired from Apollo Scientific, UK, and 4-fluoro-4′-hydroxybiphenyl was supplied by ABCR GmbH & Co. KG, Germany.
Culture conditions
C. elegans DSM 8217 (DSMZ, Germany) was grown using a similar procedure as described by Moody et al. (2000) . Briefly, fungal spores/mycelia from Sabouraud dextrose agar slants were transferred to Sabouraud dextrose agar plates and incubated for 7 days at 26°C before the agar and mycelium were aseptically homogenised in 100 ml of sterile saline solution. The homogenate (10% v/v) was used to inoculate 50 ml of fresh Sabouraud dextrose broth in 250 ml Erlenmeyer flasks, which were incubated at 28°C with shaking at 150 rpm. Control experiments were conducted in either the absence of fluorobiphenyl or C. elegans. After 72 h, 5 mg of fluorobiphenyl dissolved in dimethylformamide was added to the cultures and incubated for up to 120 h. The entire cultures (supernatant and cells) were sonicated on ice (Sonicator U200S control, IKA Labortechnik) for 10 min at 50% amplitude with intervals of 30 s every 2 min. Cultures were filtered and then extracted three times with 50 ml of ethyl acetate. Organic extracts were evaporated to dryness and finally, dissolved in 1 ml of methanol. Aqueous extracts were lyophilised and reconstituted in 1 ml methanol.
Analysis of fluorometabolites
Organic and aqueous phases in methanol were analysed by reversed phase high performance liquid chromatography (HPLC) with a Varian Prostar HPLC system equipped with a Microsorb MV-100.5 C8 column (250×4.6 mm) and a UV-VIS detector monitoring at 250 nm. Compounds were eluted with a gradient of acetonitrile/water (10-90% acetonitrile) over 28 min at a flow rate of 1 ml/min. Gas chromatography-mass spectrometry (GC-MS) analysis was conducted on pertrimethylsilylated extracts and non-derivatised culture extracts that were dissolved in ethyl acetate. Silylation was performed on lyophilised extracts by adding 50 μl N-methyl-N-(trimethyl-silyl)trifluoroacetamide and heating at 80°C for 1 h. Derivatised samples (1 µl) were injected in the splitless mode onto a HP-1 column (12 m×0.25 mm×0.33 µm) and the oven temperature held at 120°C for 2 min then raised to 300°C at 10°C/min. Non-derivatised samples (1 µl) were injected in the splitless mode and the oven temperature held at 70°C for 3 min, then raised to 250°C at 10°C/min. The mass spectrometer was operated in the scan mode.
19 F NMR spectroscopy was performed using a Varian 400 MHz spectrometer. Organic and aqueous extracts were dissolved in 800 µl of CDCl 3 or D 2 O, respectively, to provide a lock signal.
Results

Biotransformation of 4-fluorobiphenyl
It was initially noticed that between experiments there was a large variation in 4-fluorobiphenyl metabolism, which was mainly due to differences in fungal morphology. Welldispersed mycelia (1-2 mm in diameter) resulted in efficient degradation, meanwhile the formation of pellets (1.5-2 cm in diameter) resulted in no biotransformation. Of the different variables tested (temperature, aeration, shaking, etc.) that affect fungal growth, the volume of fungal suspension used as the inoculum (10% v/v) was found to be the most important for controlling the size of the pellets. Fungal biomass after 5 days' incubation was 0.56 and 0.52 g in absence and in presence of 4-fluorobiphenyl, respectively. Experiments were carried out in triplicate to test the reproducibility of 4-fluorobiphenyl degradation among different batches and the difference among the replicates was between 4% and 10%.
HPLC analysis of the organic extracts ( Fig. 1) showed that 99.7% of 4-fluorobiphenyl was degraded to a variety of more polar metabolites by C. elegans over 5 days. After 72 h, 72% of 4-fluorobiphenyl was metabolised to two major metabolites with retention times (t R ) 22 and 16.5 min (peak I and VI). After 5 days incubation, peaks I and VI remained the most predominant and four minor metabolites were observed at t R 21.5, 19, 18.3 and 17 min (II, III, IV and V). Peak I was identified as 4-fluoro-4′-hydroxybiphenyl by comparison with an authentic standard. Other standards were commercially unavailable, but it is likely that the other metabolites are hydroxylated or dihydroxylated 4-fluorobiphenyl, based on previous investigations on the biotransformation of biphenyl by C. elegans (Dodge et al. 1979) . No metabolite peaks were found in the control experiments, and no disappearance of 4-fluorobiphenyl was observed in uninoculated control flasks. GC-MS data of the silylated organically soluble products are reported in Table 1 . 4-Fluorobiphenyl and 4-fluoro-4′-hydroxybiphenyl fragmentation patterns and t R were identical to authentic standards. The sensitivity of GC-MS compared to HPLC probably accounts for the detection of the starting compound. The analyte that eluted at t R 9.95 min had a very similar mass spectrum to 4-fluoro-4′-hydroxybiphenyl and is probably a monohydroxylated fluorobiphenyl isomer. Furthermore, the compounds that eluted at 11.7 and 11.93 min had molecular ions of m/z 348, which is the expected molecular weight of silylated dihydroxylated 4-fluorobiphenyl. Analysis of the nonderivatised samples confirmed that 4-fluoro-4′-hydroxybiphenyl was the major metabolite.
Examination of aqueous extracts by HPLC showed two peaks at t R 16.2 and 18 min (Fig. 1) . It is known that C. elegans has the ability to form glucoronide and sulphate conjugates with aromatic hydrocarbons (Cerniglia et al. 1982) , and it is possible that these two highly water-soluble compounds are similar phase II metabolites. Analysis of pertrimethylsilylated aqueous extracts also revealed peaks with molecular ions m/z 267 and 356, which are consistent (Fig. 2a) plus a minor signal at −116.5 ppm. By comparison with the authentic standard, it was found that the signal at -116.8 ppm was 4-fluoro-4′-hydroxybiphenyl; 4-fluorobiphenyl was not detected (δ -115.8 ppm), which is consistent with the HPLC analysis. The other signals are likely to be mono-or dihydroxylated fluorobiphenyls that were detected by GC-MS, and the minor chemical shift changes indicate that the fluorinated ring was not substantially modified. Two signals were detected in the aqueous extract with chemical shifts at −115.58 and −115.84 ppm (Fig. 2b) and were thought to be conjugated metabolites. Fluoride ion (broad singlet δ −120 ppm) was not observed, indicating that no defluorination had occurred. In order to elucidate the nature of the water-soluble metabolites, enzymatic deconjugation was conducted by incubating with sulfatase, β-glucoronidase and β-glucosidase in phosphate buffer at 37°C for 12 h. The enzymatic reactions were extracted with ethyl acetate and analysed by GC-MS (Fig. 3) . After enzymatic deconjugation with sulfatase 4-fluoro-4′-hydroxybiphenyl and a presumed dihydroxy 4-fluorobiphenyl were detected based on their t R and mass spectra. This observation is consistent with the GC-MS analysis of the silylated aqueous phase metabolites, which suggested the presence of sulphated metabolites. 4-Fluoro-4′-hydroxybiphenyl was apparent after treatment with β-glucoronidase, but no organically soluble metabolites were detected after incubation with β-glucosidase.
Metabolism of other fluorinated biphenyls
To determine the effect of fluorine substitution at different positions and the effect of additional fluorine substitution on biodegradability, the biotransformation of 2-fluorobiphenyl, 4,4′-difluorobiphenyl and 2,3,4,5,6-pentafluorobiphenyl by C. elegans was also evaluated. HPLC analysis of cultures incubated with 5 mg of each compound showed that 2-fluorobiphenyl and 4,4′-difluorobiphenyl were completely degraded (100%) after 5 days. Cultures incubated with 2,3,4,5,6-pentafluorobiphenyl still contained the solid start- ing material at the end of the incubation period, indicating that little degradation had occurred. GC-MS analysis of organic extracts suggested the presence of various mono-and dihydroxylated products as indicated in Table 2 . Interestingly, compared with the hydroxylated metabolites from 4-fluorobiphenyl, there was an additional mono-hydroxy fluorobiphenyl and dihydroxyfluorobiphenyl observed from 2-fluorobiphenyl. One hydroxylated and one dihydroxylated metabolite were observed from 4,4′-difluorobiphenyl and some hydroxylated metabolites were detectable from 2,3,4,5,6-pentafluorobiphenyl, although, the chromatogram indicated that almost none of the starting compound was metabolised. The presence of water-soluble metabolites was evaluated in aqueous extracts by 19 F NMR. Surprisingly, no signals for organofluorine compounds were observed in the 2-fluorobiphenyl and 2,3,4,5-pentafluorobiphenyl culture extracts; two signals were detected in cultures that had been incubated with 4,4′-difluorobiphenyl with chemical shifts of −112.64 and −115.48 ppm and are probably from a single compound since the fluorine atoms would be non-equivalent after biotransformation. The 4,4′-difluorobiphenyl extract was treated with sulfatase and the aqueous phase re-analysed by 19 F-NMR, revealing no signals and indicating that enzymatic deconjugation occurred. Hence, in addition to hydroxylated metabolites of 4,4′-difluorobiphenyl, C. elegans produced a sulphate conjugate; no other conjugates were detected.
Discussion
Many enzymes can transform fluorinated derivatives of their natural substrates since substitution of hydrogen for fluorine in organic compounds has little steric effect. The biotransformation and biodegradation of fluoroaromatics such as fluorobenzoate and fluorophenol has been well characterised in microorganisms (Murphy et al. 2009 ); however, the degradation of fluorinated polycyclic hydrocarbons has been less well studied. In this paper, we determined the biotransformation products of fluorobiphenyl incubated with C. elegans, a fungus known to transform a broad range of xenobiotic compounds in an analogous fashion to mammals. C. elegans transforms 4-fluorobiphenyl to 4-fluoro-4′-hydroxybiphenyl, which is converted to the corresponding sulphate and glucuronide via phase II metabolism (Fig. 4) . Previous work reported that the C-4 position of biphenyl is the preferred site of hydroxylation by C. elegans (Dodge et al. 1979) , and in our study, 4-fluoro-4′-hydroxybiphenyl was the main organically extractable product of 4-fluorobiphenyl degradation. Conjugated biphenyl was also observed in the earlier study, but it could not be determined whether the conjugates were sulphate or glucuronide or a mixture, since the enzyme preparation used for the deconjugation contained both activities. Although the predominance of the sulphated conjugate is consistent with the observation made by Zhang et al. (1996) that the highest phase II enzyme activity in C. elegans is PAPS sulphotransferase, the absence of a glucoside conjugate is surprising, since this conjugate, in addition to sulphate and glucuronide, was detected in C. elegans cultures incubated with 1-fluoronaphthalene (Cerniglia et al. 1984) . Minor metabolites, which are probably other mono-and dihydroxylated 4-fluorobiphenyls were also detected. Earlier work using hepatic microsomes from rats showed that 4′-hydroxylated 4-fluorobipehnyl was the main metabolite (Parkinson and Safe 1982) , further illustrating the similarities in xenobiotic metabolism between C. elegans and mammals. Fluorine substitution at C-2 did not seem to have an impact on its initial transformation by C. elegans to hydroxylated 2-fluorobiphenyl, but no phase II metabolites were detectable from this substrate, indicating that fluorine at C-2 has an effect on subsequent conjugation reactions. Additional fluorine substitution results in reduced biotransformation since 2,3,4,5,6-pentafluorobiphenyl was largely undegraded, but fluorine substitution on the C4 and C4′ did not have a dramatic effect on both phase I and phase II metabolism, even though the preferred site of hydroxylation was fluorinated.
This work has demonstrated for the first time the biodegradation of fluorobiphenyl in C. elegans. The observations suggested that the substitution of fluorine in different positions on the biphenyl molecule might play an important role in blocking hydroxylation and subsequent enzymatic conjugation during metabolism. Further analysis of the purified fluorometabolites is required to give precise details of the position of hydroxylation, which would clarify the directing effect of fluorine substitution on the hydroxylation reactions.
